Status:
COMPLETED
The Acute Effect of Atorvastain on Renal Function in Patients With Type II Diabetes
Lead Sponsor:
Regional Hospital Holstebro
Collaborating Sponsors:
Medical Research
Conditions:
Healthy Subjects
Eligibility:
All Genders
40-70 years
Phase:
PHASE4
Brief Summary
We wanted to test the hypothesis that acute treatment with atorvastatin changes renal sodium excretion, glomerular filtration rate, tubular function and vasoactive hormones in patients with type II di...
Eligibility Criteria
Inclusion
- Age: 40-70 yrs
- estimated GFR between 30 and 90 ml/min
- BMI\<35
- Fertile women had to use oral contraceptives or IUD
- HbA1c\< 10%
- Urine-albumin\<1,5 g/l
Exclusion
- Treatment with insulin
- Cerobrovascular insult or other disease of the brain
- Insufficiency of the heart or lungs
- Liverdisease with ALAT \> 200 U/L
- hemoglobin \< 7,0 mmol/l
- Cancer
- Alcohol abuse
- Medical treatment with psycopharmaca or/and analgetics
- Pregnancy and breast feeding, 10 blood donation one month before the study.
Key Trial Info
Start Date :
September 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2008
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00678522
Start Date
September 1 2007
End Date
May 1 2008
Last Update
May 15 2008
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Reseach, Holstebro Hospital
Holstebro, Denmark, 5500
2
Department of Medical Research, Holstebro Hospital
Holstebro, Denmark, 7500